![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1776192
¼¼°èÀÇ ÈÞ´ë¿ë X¼± ±â±â ½ÃÀå : ½ÃÀå ÀλçÀÌÆ®, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2032³â)Portable X-Ray Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 26¾ï 1,356¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2025³âºÎÅÍ 2032³â±îÁö ¿¹Ãø ±â°£ µ¿¾È CAGR 6.86%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 44¾ï 1,184¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°üÁúȯ, Á¤Çü¿Ü°ú Áúȯ, Ä¡°ú Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÈÞ´ë¿ë X¼± ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ÆíÀǼºÀ» ³ôÀ̰í ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ´Â ºñħ½ÀÀû Á¶±â Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÏ¸é¼ ÀÌ·¯ÇÑ ¼ö¿ä ±ÞÁõ¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ±â¼ú ¹ßÀü°ú ¾÷°è ÁÖ¿ä ¾÷üµéÀÇ Á¦Ç° °³¹ß °È·Î ÈÞ´ë¿ë ¿µ»ó Áø´Ü ½Ã½ºÅÛÀÇ ±â´É ¹× äÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃËÁø¿äÀεéÀÌ °áÇÕµÇ¾î ½ÃÀå ¼ºÀå¿¡ ¸Å¿ì À¯¸®ÇÑ È¯°æÀ» Á¶¼ºÇϰí ÀÖÀ¸¸ç, 2025³âºÎÅÍ 2032³â±îÁö ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀº °ß°íÇϰí Áö¼ÓÀûÀÎ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÈÞ´ë¿ë X¼± ±â±âÀÇ ½ÃÀå ¿ªÇÐ:
¸¸¼ºÁúȯ ¹× ³ëÈ °ü·Ã ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÏ¸é¼ ÈÞ´ë¿ë X¼± ±â±âÀÇ ¼ö¿ä Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë X¼± ±â±â´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼ Á¢±ÙÀÌ ¿ëÀÌÇϰí È¿À²ÀûÀÌ¸ç °íǰÁúÀÇ ¿µ»ó ¼Ö·ç¼ÇÀ» Á¦°øÇϱ⠶§¹®ÀÔ´Ï´Ù.
¿µ±¹ ½ÉÀåÀç´Ü(British Heart Foundation)¿¡ µû¸£¸é(2024³â), Àü ¼¼°èÀûÀ¸·Î ¾à 6¾ï 2,000¸¸ ¸íÀÌ ½ÉÀå ¹× ¼øÈ¯±â°è ÁúȯÀ» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº À¯º´·üÀº ½ÉÀå Å©±â ¸ð´ÏÅ͸µ, ü¾× Àú·ù °¨Áö, Æó ÇÕº´Áõ Áø´ÜÀ» À§ÇØ Æ¯È÷ ÈäºÎ X¼±¿Í °°Àº ºó¹øÇÑ ÇöÀå ¿µ»ó Áø´ÜÀÇ Çʿ伺À» °Á¶ÇÕ´Ï´Ù. ÈÞ´ë¿ë X¼± ½Ã½ºÅÛÀº ¼øÈ¯±â º´µ¿, ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç µî¿¡¼ ¸Å¿ì À¯¿ëÇϸç, ħ´ë ¿·¿¡¼ ½Å¼ÓÇÑ ¿µ»ó Áø´ÜÀ» ÅëÇØ Àû½Ã¿¡ ÀÓ»óÀû ÆÇ´ÜÀ» µ½°í ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ¼¼°èº¸°Ç±â±¸(WHO, 2023³â)¿¡ µû¸£¸é 2022³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î ¾à 17¾ï 1,000¸¸ ¸íÀÌ °ñ°üÀý¿°, °ñÀý µî ±Ù°ñ°Ý°è ÁúȯÀ» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ÈÞ´ë¿ë X¼± ±â±â´Â °ñÀý, »ÀÀÇ º¯Çü, ÅðÇ༺ º¯È¸¦ ÇöÀå¿¡¼ Æò°¡ÇÒ ¼ö Àֱ⠶§¹®¿¡ Á¤Çü¿Ü°ú Áúȯ¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.
¶ÇÇÑ, Ä¡°ú ÀÇ·á ¹®Á¦µµ ÈÞ´ë¿ë X¼± ±â¼ú ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO, 2023³â)ÀÇ ÀÚ·á¿¡ µû¸£¸é, 2022³â¿¡´Â Àü ¼¼°è 20¾ï ¸íÀÌ ¿µ±¸Ä¡ ¿ì½ÄÁõÀ» ¾Î°í ÀÖÀ¸¸ç, 5¾ï 1,400¸¸ ¸íÀÇ ¾î¸°À̰¡ Á¥´Ï¸¦ ¾Î°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 20¼¼ ÀÌ»ó ¼ºÀÎÀÇ °ÅÀÇ 7%°¡ Ä¡¾Æ¸¦ ¿ÏÀüÈ÷ »ó½ÇÇϰí, 60¼¼ À̻󿡼´Â 23%±îÁö Ä¡¾Æ°¡ »ó½ÇµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼öÄ¡´Â ƯÈ÷ Áö¿ª Áø·á¼Ò, ³óÃÌ Áö¿ª ¾Æ¿ô¸®Ä¡ ÇÁ·Î±×·¥, ³ëÀÎ ÀÇ·á¿¡¼ ÀÏ»óÀûÀÎ Ä¡°ú Áø´ÜÀÇ Çʿ伺ÀÌ ³ô´Ù´Â °ÍÀ» º¸¿©ÁÝ´Ï´Ù. ÇÚµåÇïµå Ä¡°ú¿ë X¼± ½Ã½ºÅÛÀº Á¶±â ¹ß°ß ¹× Ä¡·á °èȹÀ» À§ÇÑ ½Ç¿ëÀûÀ̰í È¿°úÀûÀÎ ¼Ö·ç¼ÇÀÔ´Ï´Ù.
¶ÇÇÑ, Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ Áõ°¡´Â ÈÞ´ë¿ë X¼± ±â±âÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 4¿ù, »ï¼ºÀÇ µðÁöÅÐ X¼± ¹× ÃÊÀ½ÆÄ Áø´Ü ±â±âÀÇ ¹Ì±¹ º»»çÀÎ Boston ImagingÀº ÇÁ¸®¹Ì¾ö AccE GM85 µðÁöÅÐ X¼± ±â±âÀÇ »õ·Î¿î ±¸¼ºÀÎ GM85 FitÀ» ¹ßÇ¥Çß½À´Ï´Ù. GM85 FitÀº »ç¿ëÀÚ Áß½ÉÀÇ µðÀÚÀÎÀ» Ư¡À¸·Î Çϸç, È¿À²ÀûÀ̰í È¿°úÀûÀΠȯÀÚ Ä¡·á¸¦ °ÈÇϱâ À§ÇÑ GM85 FitÀº ÃÖ±Ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ¹Ì±¹ ³» »ó¾÷Àû »ç¿ë ½ÂÀÎ(510(k))À» ȹµæÇß½À´Ï´Ù.
µû¶ó¼, À§ÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀº 2025³âºÎÅÍ 2032³â±îÁö ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±×·¯³ª ¹æ»ç¼± À¯¹ß ÁúȯÀÇ À§Çè°ú ¹Ýº¹ÀûÀÎ ³ëÃâ, ´ëü ¿É¼ÇÀÇ °¡¿ë¼º µîÀº ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â ÁÖ¿ä Á¦¾à ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ ºÎ¹® ºÐ¼®:
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°(µðÁöÅÐ X¼± ±â±â, ¾Æ³¯·Î±× X¼± ±â±â), È޴뼺º°(ÇÚµåÇïµå, ¸ð¹ÙÀÏ), ÃÖÁ¾»ç¿ëÀÚº°(º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü¼¾ÅÍ, Çмú ¹× ¿¬±¸½Ç), Áö¿ªº°(ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ±âŸ Áö¿ª)
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ Á¦Ç° À¯Çüº°·Î´Â µðÁöÅÐ X¼± ±â±â°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÈÞ´ë¿ë À̹Ì¡ ½ÃÀåÀÇ µðÁöÅÐ X¼± ±â±â ºÎ¹®Àº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, ÇöÀå Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¾÷°è ¼±µÎ ¾÷üµéÀÇ Àü·«Àû Çõ½Å¿¡ ÈûÀÔ¾î °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. ÃֽŠÈÞ´ë¿ë µðÁöÅÐ X¼± ±â±â´Â ÄÄÆÑÆ®Çϰí ÀÎü°øÇÐÀûÀÎ µðÀÚÀÎ, ¹«¼± ¿¬°á, °íÇØ»óµµ Æò¸é ÆÐ³Î °ËÃâ±â, ºü¸¥ À̹ÌÁö ¼öÁý ±â´É µîÀ» °®Ãß°í ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ Æ¯Â¡À¸·Î ÀÎÇØ ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç(ICU), ¼ö¼ú½Ç, À̵¿Áø·á½Ç, ÀçÅÃÀÇ·á ȯ°æ µî ´Ù¾çÇÑ ÀÓ»óÇöÀå¿¡¼ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ º´»ó¿¡¼ ½Ç½Ã°£ ¿µ»ó Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÀÌ ½Ã½ºÅÛÀº º´¿ø ³» À̼ÛÀÇ Çʿ伺À» ÁÙÀÌ°í °ü·Ã À§ÇèÀ» ÃÖ¼ÒÈÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ÀÓ»ó ¿öÅ©Ç÷ο츦 °£¼ÒÈÇÏ¿© Ã̰¢À» ´ÙÅõ´Â »óȲ¿¡¼ Áß¿äÇÑ ÀÇ»ç°áÁ¤À» ½Å¼ÓÇÏ°Ô ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
¶ÇÇÑ, µðÁöÅÐ X¼± ½Ã½ºÅÛÀº ¾Æ³¯·Î±× ±â±â¿¡ ºñÇØ ¹æ»ç¼± ÇÇÆø·®ÀÌ Àû´Ù´Â ÀåÁ¡ÀÌ ÀÖ¾î ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎÀÇ ¾ÈÀü¼ºÀ» ³ôÀÔ´Ï´Ù. Ãʱâ ÅõÀÚºñ¿ëÀº ³ôÁö¸¸ Çʸ§, ¾àǰ, ó¸® ±â±â°¡ ÇÊ¿ä ¾ø±â ¶§¹®¿¡ Àå±âÀûÀ¸·Î ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. µðÁöÅÐ X¼± ºÐ¾ß´Â ´Ù¿ëµµ¼º°ú ±â´É¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ßÀ» ÅëÇØ ÁøÈÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Áö¸à½º Çï½Ã´Ï¾î½º(Siemens Healthineers)´Â 2022³â 7¿ù ħ´ë ¿·¿¡¼ ÃÔ¿µÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÈ ÈÞ´ë¿ë µðÁöÅÐ X¼± ±â±âÀÎ 'Mobilett Impact'¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ±â±â´Â ¿ÏÀüÇÑ µðÁöÅÐ ÅëÇÕ, ¹«¼± µ¥ÀÌÅÍ Àü¼Û, °æÁ¦ÀûÀÎ °¡°Ý, º´¿ø ½Ã½ºÅÛ¿¡ ¿ÏÀüÈ÷ ÅëÇÕµÈ ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ·¯ÇÑ ±â¼ú ¹ßÀü, ÀÓ»ó Àû¿ë È®´ë, Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº ÷´Ü µðÁöÅÐ X¼± ½Ã½ºÅÛÀÇ Ã¤ÅÃÀ» °¡¼ÓÈÇϰí ÈÞ´ë¿ë X¼± ±â±â ¼¼°è ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì°¡ Àüü ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù:
ºÏ¹Ì´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ 2024³â ÈÞ´ë¿ë X¼± ±â±â ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿ìÀ§´Â ÁÖ·Î ½ÉÇ÷°üÁúȯ, ¾Ï, Ä¡°ú Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷µéÀÇ Á¦Ç° °³¹ß Ȱµ¿°ú Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶ó°¡ ÀÌ Áö¿ªÀÇ ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» Á¾ÇÕÇØ º¼ ¶§, ºÏ¹Ì´Â ÈÞ´ë¿ë X¼± ±â±â ¼¼°è ½ÃÀå¿¡¼ ÁÖ¿ä ½ÃÀåÀ̶ó°í ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC, 2024³â)¿¡ µû¸£¸é 20¼¼ ÀÌ»ó ¼ºÀÎ ¾à 20¸í Áß 1¸íÀÌ °ü»óµ¿¸Æ¼º ½ÉÀåÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, ¹Ì±¹¿¡¼ °¡Àå ÈçÇÑ ½ÉÀåÁúȯÀÌ µÇ¾ú½À´Ï´Ù. ÀÌó·³ ½ÉÇ÷°üÁúȯÀÇ ºÎ´ãÀÌ Å©±â ¶§¹®¿¡ ºó¹øÇÑ Áø´Ü ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϸç, ƯÈ÷ ÀÀ±ÞÀÇ·á ¹× ±¸±ÞÀÇ·á ÇöÀå¿¡¼´Â ºÒ¾ÈÁ¤ÇÑ È¯ÀÚ¸¦ À̵¿½ÃŰÁö ¾Ê°í ½ÉÀå°ú ÆóÀÇ »óŸ¦ Æò°¡Çϱâ À§ÇÑ ½Å¼ÓÇÑ ÈäºÎ ¿µ»ó Áø´ÜÀ» À§ÇØ ÈÞ´ë¿ë X¼± ½Ã½ºÅÛÀÌ ÇʼöÀûÀÔ´Ï´Ù.
CDC¿¡ µû¸£¸é, ¹Ì±¹¿¡¼´Â ¸Å³â ¾à 80¸¸ 5,000¸íÀÌ ½ÉÀ帶ºñ·Î °íÅë¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »ç°Ç¿¡¼´Â ÆóºÎÁ¾, Ç÷°ü º¯È, ½É¹ÚÁ¶À²±â µîÀÇ ÀåÄ¡ ÀåÂø°ú °°Àº ÇÕº´ÁõÀ» °¨ÁöÇϱâ À§ÇØ Ä§´ë ¿·¿¡¼ Áï°¢ÀûÀÎ ÃÔ¿µÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹¾Æ ÀÀ±Þ½ÇÀ̳ª ÁßȯÀڽǿ¡¼ °í¼º´É ÈÞ´ë¿ë X¼± ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ ´õ¿í °Á¶µÇ°í ÀÖ½À´Ï´Ù.
¸¶Âù°¡Áö·Î GLOBOCAN 2024ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¹Ì±¹ÀÇ ¾Ï ȯÀÚ ¼ö´Â 2022³â 238¸¸ ¸í, 2030³â¿¡´Â 279¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ¾Ï ȯÀÚ ¼öÀÇ Áõ°¡·Î ÀÎÇØ Áø´Ü, Ä¡·á °èȹ, ÀüÀÌ ¸ð´ÏÅ͸µ µî ¾Ï Ä¡·áÀÇ °¢ °æ·Î¿¡¼ Áö¼ÓÀûÀÎ ¿µ»ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë X¼± ±â±â´Â ƯÈ÷ °Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚ³ª ÀÔ¿ø Ä¡·á ÁßÀΠȯÀڵ鿡°Ô °£ÆíÇϰí ÀçÇö¼º ³ôÀº ÃÔ¿µÀ» °¡´ÉÇϰÔÇÔÀ¸·Î½á Á¾¾çÇÐ Ä¡·á¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, CDC(2024³â)´Â Ä¡¾Æ °Ç°°ú °ü·ÃÇÏ¿© û¼Ò³â(12-19¼¼) 10¸í Áß 1¸í, ¼ºÀÎ(20-64¼¼) 5¸í Áß 1¸íÀÌ ¿µ±¸Ä¡¿¡ ÃÖ¼Ò 1°³ ÀÌ»óÀÇ ÃæÄ¡¸¦ °¡Áö°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌó·³ ÃæÄ¡°¡ ³Î¸® ÆÛÁ® ÀÖ´Â »óȲ¿¡¼, ƯÈ÷ Áö¿ª Áø·á¼Ò³ª ³óÃÌ Áö¿ª, À̵¿ Áø·á¼Ò¿¡¼ »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ Áø´Ü µµ±¸°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. Ä¡°ú¿ë ÇÚµåÇïµå X¼± ½Ã½ºÅÛÀº Á¶±â ¹ß°ß ¹× ¿¹¹æ Ä¡°ú Ä¡·á¸¦ Áö¿øÇÏ°í °øÁß º¸°ÇÀÇ ÇÊ¿ä¿Í Á¢±Ù¼º °ÝÂ÷¸¦ ÇØ¼ÒÇϱâ À§ÇØ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
2025³â 1¿ù, X¼± ¿µ»ó Áø´Ü ±â¼úÀÇ ¼±µµÀû Çõ½Å ±â¾÷ÀÎ OXOS Medical(R)Àº MC2 ÈÞ´ë¿ë X¼± ½Ã½ºÅÛÀÌ FDA 510(k) ½ÂÀÎÀ» ȹµæÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. À̹ø ½ÂÀÎÀº MC2 ½Ã½ºÅÛÀÇ ÀÓ»óÀû ¾ÈÀü¼º°ú À¯È¿¼ºÀ» ÀÔÁõÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¹Ì±¹ ÇコÄÉ¾î ½ÃÀå¿¡¼ ÆÇ¸ÅÇÒ ¼ö ÀÖ´Â ±æÀ» ¿¾îÁÖ¾ú½À´Ï´Ù.
ÀÌ·¯ÇÑ °³¹ßÀº ÇöÀå Áø·á ¿µ»ó Áø´Ü, ¿Ü°ú ¼ö¼úÀÇ À̵¿¼º, Áø´Ü ½Ã°£ ´ÜÃà¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°øÀÚµéÀº ÄÄÆÑÆ®ÇÏ°í »ç¿ëÇϱ⠽¬¿î °í¼º´É À̹Ì¡ ¼Ö·ç¼ÇÀ» Á¡Á¡ ´õ ¼±È£Çϰí ÀÖÀ¸¸ç, MC2¿Í °°Àº FDA ÀÎÁõÀ» ¹ÞÀº ±â¼úÀº ½ÃÀåÀÇ ½Å·Ú¼ºÀ» ³ôÀ̰í ÀÀ±Þ ÀÇ·á, ¿Ü·¡ ȯÀÚ, ±º´ë, ¿ø°ÝÀÇ·á ȯ°æ¿¡¼ äÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
µû¶ó¼ ¾Õ¼ ¾ð±ÞÇÑ ¸ðµç ¿äÀÎÀ¸·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â GE HealthCare, Fujifilm Holdings Corporation, Halomedicals Systems, REMEDI Inc., Hamamatsu Photonics K.K., Siemens Healthineers AG, Koninklijke Philips N.V., Kiran, Carestream Health, Kiran, Carestream Health., Shimadzu Corporation, Samsung Electronics Co., Ltd., Hologic., MinXray, Inc., Konica Minolta, Inc., Agfa Corporate, Dental Imaging Technologies Corporation., Teledyne Vision Solutions, Radmedix, Genoray Co., Ltd., Acteon µîÀÔ´Ï´Ù.
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀåÀÇ ÃÖ±Ù °³¹ß Ȱµ¿:
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀå Á¶»ç º¸°í¼ÀÇ ÁÖ¿ä ¿äÁ¡
ÈÞ´ë¿ë X¼± ±â±â ½ÃÀå ÀÚÁÖ ¹¯´Â Áú¹®
Portable X-Ray Devices Market by Product Type (Digital X-ray Devices and Analog X- ray Devices), Portability (Handheld and Mobile), End-User (Hospitals and Clinics, Diagnostic Centers, and Academic and Research Labs), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of chronic disorders, increasing demand for non-invasive and early diagnostic solutions, and increased product developmental activities.
The portable X-ray devices market was valued at USD 2,613.56 million in 2024, growing at a CAGR of 6.86% during the forecast period from 2025 to 2032 to reach USD 4,411.84 million by 2032. The demand for portable X-ray devices is gaining strong momentum, fueled by the rising prevalence of chronic disorders such as cardiovascular diseases, orthopedic conditions, and dental ailments. This surge is further amplified by the growing need for non-invasive, early-stage diagnostic solutions that improve clinical outcomes while enhancing patient comfort. In parallel, ongoing advancements in technology and intensified product development efforts by key industry players are expanding the capabilities and adoption of portable imaging systems. Together, these drivers are fostering a highly favorable environment for market growth, firmly positioning the portable X-ray devices market for robust and sustained expansion from 2025 to 2032.
Portable X-Ray Devices Market Dynamics:
The growing burden of chronic and age-related diseases is significantly contributing to the rising demand for portable X-ray devices, as these tools offer accessible, efficient, and high-quality imaging solutions across various healthcare settings.
According to the British Heart Foundation (2024), approximately 620 million people worldwide were living with heart and circulatory diseases. This high prevalence underscores the need for frequent and point-of-care diagnostic imaging, particularly chest X-rays, to monitor heart size, detect fluid accumulation, or diagnose pulmonary complications. Portable X-ray systems are invaluable in cardiology units, emergency rooms, and intensive care settings, where rapid bedside imaging can support timely clinical decisions and improve patient outcomes.
Additionally, according to the World Health Organization (WHO, 2023), in 2022, approximately 1.71 billion people suffered from musculoskeletal conditions globally, which includes osteoarthritis, bone fractures, among others. Portable X-ray devices play a crucial role in orthopedic conditions by enabling on-site assessment of fractures, bone deformities, and degenerative changes, especially in elderly or immobile patients who cannot be easily transported to radiology departments.
Moreover, dental health issues are a major driver of market growth for portable X-ray technology. As per World Health Organization (WHO, 2023) data, 2 billion people worldwide suffered from caries in permanent teeth in 2022, with 514 million children affected in their primary teeth. Furthermore, complete tooth loss impacts nearly 7% of adults over 20, rising to 23% in those above 60 years. These figures indicate a substantial need for routine dental diagnostics, especially in community clinics, rural outreach programs, and geriatric care, where portable, handheld dental X-ray systems offer a practical and effective solution for early detection and treatment planning.
Additionally, the increase in product launches and approvals is further boosting the adoption of portable X-ray devices. For instance, in April 2022, Boston Imaging, the U.S. headquarters of Samsung digital radiography and ultrasound systems, introduced the GM85 Fit, a new configuration of the premium AccE GM85 digital radiography device. Featuring a user-centric design, the GM85 Fit aimed to enhance efficient and effective patient care. It recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use in the USA.
Hence, due to the above-mentioned factors, the portable X-ray devices market is anticipated to experience substantial growth during the forecast period from 2025 to 2032.
However, the repeated exposure associated with the risk of radiation-induced conditions, availability of alternative options, among others, are some of the key constraints that may limit the growth of the portable X-ray devices market.
Portable X-Ray Devices Market Segment Analysis:
Portable X-Ray Devices Market by Product Type (Digital X-ray Devices and Analog X-ray Devices), Portability (Handheld and Mobile), End-User (Hospitals and Clinics, Diagnostic Centers, and Academic & Research Labs), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the portable X-ray devices market, the digital X-ray devices category is estimated to account for the largest market share in 2024. The digital X-ray systems segment within the portable imaging market is witnessing remarkable growth, propelled by rapid technological advancements, the rising demand for point-of-care diagnostics, and strategic innovations from leading industry players. Contemporary portable digital X-ray systems are engineered with compact, ergonomic designs, wireless connectivity, high-resolution flat panel detectors, and swift image acquisition capabilities.
These features make them indispensable across a variety of clinical settings, including emergency departments, intensive care units (ICUs), operating rooms, mobile medical units, and home healthcare environments. By facilitating real-time diagnostic imaging at the patient's bedside, these systems not only reduce the need for intra-hospital transport, thereby minimizing associated risks but also streamline clinical workflows and accelerate critical decision-making in time-sensitive scenarios.
Moreover, digital X-ray systems offer the advantage of lower radiation exposure compared to analog devices, enhancing safety for both patients and healthcare staff. While the initial investment may be higher, digital systems reduce long-term costs by eliminating the need for film, chemicals, and processing equipment. The digital X-ray category is evolving through ongoing research and development to improve versatility and functionality. For example, in July 2022, Siemens Healthineers launched the Mobilett Impact, a portable digital X-ray device designed for bedside imaging. It offers full digital integration, wireless data transmission, and is economically priced, making it a cost-effective solution fully integrated into hospital systems.
Collectively, these technological advancements, expanded clinical applications, and ongoing innovation are accelerating the adoption of sophisticated digital X-ray systems, thereby playing a pivotal role in the continued growth of the global portable X-ray devices market.
North America is expected to dominate the overall portable X-ray devices market:
North America is projected to hold the largest share of the portable X-ray devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic disorders, including cardiovascular diseases, cancer, and dental disorders. Additionally, product developmental activities by the leading players in the market and the presence of established health care infrastructure are further anticipated to boost the market for portable X-ray device market in the region. Collectively, these factors are positioning North America as the leading market in the global portable X-ray devices market.
According to the Centers for Disease Control and Prevention (CDC, 2024), approximately 1 in 20 adults aged 20 and older were living with coronary heart disease, making it the most common form of heart disease in the US. This high burden of cardiovascular disease necessitates frequent diagnostic monitoring, particularly in emergency and critical care settings where portable X-ray systems are essential for rapid chest imaging to assess cardiac and pulmonary conditions without moving unstable patients.
In addition to this, according to the source, the CDC also reported that approximately 805,000 people suffered from heart attacks annually in the US. These events often require immediate bedside imaging to detect complications such as pulmonary edema, vascular changes, or device placements (e.g., pacemakers), further underscoring the need for high-performance portable X-ray systems in emergency departments and intensive care units.
Similarly, data from GLOBOCAN 2024 indicated that cancer cases in the US reached 2.38 million in 2022, with projections rising to 2.79 million by 2030. This escalating cancer burden significantly increases the demand for continuous imaging across oncology pathways, including diagnostics, treatment planning, and monitoring of metastasis. Portable X-ray devices play a pivotal role in oncology care by enabling convenient, repeatable imaging, particularly for patients with limited mobility or those undergoing inpatient treatment.
Further, in dental health, the CDC (2024) stateed that 1 in 10 adolescents (aged between 12 and 19) and 1 in 5 adults (aged between 20 and 64) have at least one untreated cavity in their permanent teeth. This widespread incidence of dental decay calls for accessible and cost-effective diagnostic tools, especially in community clinics, rural areas, and mobile health units. Handheld and portable dental X-ray systems are increasingly being adopted to support early detection and preventive dental care, addressing both public health needs and gaps in access.
In January 2025, OXOS Medical(R), a leading innovator in X-ray imaging technology, announced that its MC2 Portable X-ray System received FDA 510(k) clearance, marking a significant milestone in portable diagnostic imaging. The regulatory approval not only affirms the MC2 system's clinical safety and efficacy but also paves the way for its commercial availability across the U.S. healthcare market.
This development is expected to accelerate growth in the portable X-ray devices market, driven by increasing demand for point-of-care imaging, surgical mobility, and faster diagnostic turnaround times. As healthcare providers increasingly prioritize compact, user-friendly, and high-performance imaging solutions, FDA-cleared technologies like the MC2 reinforce market confidence and stimulate adoption across emergency care, outpatient settings, military, and remote healthcare environments.
Hence, all the aforementioned factors are anticipated to boost the market for portable X-ray devices in the forthcoming years.
Portable X-Ray Devices Market Key Players:
Some of the key market players operating in the portable X-ray devices market include GE HealthCare, Fujifilm Holdings Corporation, Halomedicals Systems, REMEDI Inc., Hamamatsu Photonics K.K., Siemens Healthineers AG, Koninklijke Philips N.V., Kiran, Carestream Health., Shimadzu Corporation, Samsung Electronics Co., Ltd., Hologic., MinXray, Inc., Konica Minolta, Inc., Agfa Corporate, Dental Imaging Technologies Corporation., Teledyne Vision Solutions, Radmedix, Genoray Co., Ltd., Acteon, and others.
Recent Developmental Activities in the Portable X-Ray Devices Market:
Key takeaways from the portable X-ray devices market report study
Target audience who can benefit from this portable X-ray devices market report study
Frequently Asked Questions for the Portable X-Ray Devices Market: